# Junta clínica — PT-pseudo_acad53162dba (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_acad53162dba",
  "pid": "PT-pseudo_acad53162dba",
  "task": 1,
  "psa": 4.0,
  "age": 65,
  "months": 3,
  "pirads": "4",
  "psad": 0.07,
  "psav": 0.78,
  "psap": 3.5,
  "vol": 56.95,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.6783018,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 4 ng/mL. PI-RADS 4. PSAD 0.07. Prostate volume 57 mL. csPCa 0.68.",
  "pmhx": [],
  "allergies": [
    "NSAIDs"
  ],
  "vitals": {
    "weight": "88 kg",
    "height": "185 cm",
    "bmi": "25.7",
    "bp": "121/78 mmHg",
    "hr": "77 bpm",
    "smoking": "Ex-smoker (40 pack-yr, quit 2013)",
    "last_dental": "2 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "01 Mar 2025",
  "enc_ref": "Dr. T. Hendriks (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical reassessment is underway after a recent LUMC prostate MRI and a steady increase in prostate-specific antigen levels."
    },
    {
      "s": "History",
      "t": "Aged 65, the individual works as a retired accountant with no documented comorbidities, active prescriptions, or prior biopsy history (bucket None). Tobacco use ceased in 2013 after accumulating 40 pack-years. Marital status is married, though he currently maintains a solo household where his adult daughter acts as the main point of contact. Lower urinary tract symptoms remain negligible, scoring a 7 on the 35-point IPSS scale. Physical activity includes biweekly light resistance training, while alcohol consumption stays near one unit weekly. Past medical events are limited to a routine cataract procedure three years prior and a recent hearing evaluation for mild age-related changes. He has consistently opted out of clinical trials and reports no additional systemic issues."
    },
    {
      "s": "Physical examination",
      "t": "DRE: The exam confirms a normal prostate, symmetrically enlarged yet smooth, lacking any focal nodules, asymmetry, or tenderness. General assessment shows stable vital signs and a body mass index of 25.7. Auscultation of the heart and lungs yields clear tones, with absent peripheral swelling or palpable lymph nodes."
    }
  ],
  "occupation": "retired accountant",
  "marital": "Married",
  "living": "Lives alone; adult daughter is primary contact",
  "next_of_kin": "Sibling (brother)",
  "recent_other": [
    "Audiology — hearing test"
  ],
  "alcohol": "1 units / week",
  "exercise": "Light weight-training at home, 2x/week",
  "ipss": "IPSS score: 7/35 (mild LUTS)",
  "admin": "Patient declined research participation previously; respect for AS-related trials.",
  "mri_hospital": "LUMC (Leiden)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_acad53162dba
Task: 1

Encounter: Urology - outpatient on 01 Mar 2025.
Referrer: Dr. T. Hendriks (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 65-year-old male
  - PSA: 4.0 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.07 ng/mL²
  - PSA velocity: 0.78 ng/mL/yr
  - Prior PSA: 3.5 ng/mL
  - Prostate volume: 56.95 mL
  - Months since last PSA: 3
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.6783018 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NSAIDs
  - Additional notes: PSA 4 ng/mL. PI-RADS 4. PSAD 0.07. Prostate volume 57 mL. csPCa 0.68.

Vitals: weight 88 kg, height 185 cm, BMI 25.7, BP 121/78 mmHg, HR 77 bpm. Smoking: Ex-smoker (40 pack-yr, quit 2013).

Chief complaint: Clinical reassessment is underway after a recent LUMC prostate MRI and a steady increase in prostate-specific antigen levels.

History: Aged 65, the individual works as a retired accountant with no documented comorbidities, active prescriptions, or prior biopsy history (bucket None). Tobacco use ceased in 2013 after accumulating 40 pack-years. Marital status is married, though he currently maintains a solo household where his adult daughter acts as the main point of contact. Lower urinary tract symptoms remain negligible, scoring a 7 on the 35-point IPSS scale. Physical activity includes biweekly light resistance training, while alcohol consumption stays near one unit weekly. Past medical events are limited to a routine cataract procedure three years prior and a recent hearing evaluation for mild age-related changes. He has consistently opted out of clinical trials and reports no additional systemic issues.

Physical examination: DRE: The exam confirms a normal prostate, symmetrically enlarged yet smooth, lacking any focal nodules, asymmetry, or tenderness. General assessment shows stable vital signs and a body mass index of 25.7. Auscultation of the heart and lungs yields clear tones, with absent peripheral swelling or palpable lymph nodes.

Patient info: retired accountant; Married; Lives alone; adult daughter is primary contact.
Next of kin: Sibling (brother).

Lifestyle: alcohol 1 units / week; exercise Light weight-training at home, 2x/week; IPSS score: 7/35 (mild LUTS).

Recent other appointments: Audiology — hearing test.
Admin: Patient declined research participation previously; respect for AS-related trials.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.81
  uncertainty  +/- 0.08 epistemic (95% band 0.65-0.96); among patients I cannot tell apart the outcome was 0.71 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = none recorded (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 65 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 4 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 56.95 mL (1% of my signal; from log_vol, vol) · PSA density = 0.07 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.68 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 4
  important  prior biopsy = None
  noted      age = 65 · DRE = Normal · PSA = 4 ng/mL · prostate volume = 56.95 mL · PSA density = 0.07 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: clear — the rule matched the reading urologist in 24 of 24 labelled cases

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 24 men I have seen in this same situation (None prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 0.85: PI-RADS NA, PSA 4.5, PSAD 0.095, age 67, DRE Normal -> DEFER (clear). He wrote: "Normal MRI. No biopsy"
  2. distance 1.27: PI-RADS 4, PSA 2.11, PSAD 0.058, age 59, DRE Normal -> BIOPSY (clear). He wrote: "P4 and LUTS symptoms. Note , low PSA."
  3. distance 1.60: PI-RADS 4, PSA 4.8, PSAD 0.086, age 65, DRE Nodus -> BIOPSY (clear). He wrote: "P4 in patient 65 years."

PRECEDENT: BIOPSY (weighted vote 0.55 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 4
  important  prior biopsy = None · age = 65
  noted      family history = not opened (0 of 91) · DRE = Normal · PSA = 4 ng/mL · prostate volume = 56.95 mL · PSA density = 0.07
  not used   csPCa probability, comorbidity
CONFIDENCE: borderline — the library is right 92% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 24 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   PI-RADS = 4
  important  age = 65 · PSA = 4 ng/mL
  noted      prior biopsy = None · family history = not opened (0 of 91) · DRE = Normal · prostate volume = 56.95 mL · PSA density = 0.07 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines suggest that a PI-RADS threshold of $\ge 3$ is used to trigger a biopsy. The guideline states, "a PI-RADS threshold of $\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of BIOPSY p(biopsy) = 0.81 is high, but the guideline treats the PI-RADS score as the primary trigger. The guideline suggests that a PI-RADS threshold of $\ge 3$ is used to trigger biopsy, which is what the EXPERT-COHORT confirms. The guideline makes the PI-RADS score decisive, whereas EXPERT-STRUCTURED marked prior biopsy = None as decisive. The guideline suggests that in biopsy-naïve patients, a PI-RADS threshold of $\ge 3$ is used, which is what EXPERT-COHORT confirms. The guideline requires a comparison MRI, which is a fact the panel does not represent.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: None means the guideline suggests a PI-RADS $\ge 3$ threshold is used, which means biopsy is indicated if PI-RADS is 4.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA trend: the guideline does not explicitly state a requirement for PSA trend, but the context of the case involves a steady increase.
laboratory_results - the PSA density: the guideline suggests that a PSA-D cut-off of $0.15 \text{ ng/mL/cc}$ may guide the decision, and this patient's value is $0.07 \text{ ng/mL}^2$.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges on whether the PI-RADS 4 score, combined with the lack of prior biopsy, meets the EAU threshold for biopsy, and what the previous notes confirm regarding surveillance.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> What does the mpMRI prose state regarding lesion size, extraprostatic extension, and comparison against an earlier study?
  psa_trend (get_psa_trend) -> What does the PSA trend indicate regarding the steady increase in PSA levels?
  previous_notes (get_previous_notes) -> What does the management context state regarding the prior biopsy status, surveillance protocol, and planned treatment?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What should be done given the PI-RADS = 4 and prior biopsy = None?
  Q2. What does the radiology_report state regarding whether the lesion is compared against an earlier study?
  Q3. What does the psa_trend indicate regarding the steady increase in PSA levels?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Prostate MRI | Leiden University Medical Center
The mpMRI prose states: "T2-weighted sequences highlight a discrete hypointense focus measuring roughly 11 x 9 mm within the right peripheral zone at the mid-gland level. This area exhibits pronounced diffusion restriction alongside low ADC signal. Dynamic contrast phases reveal early, focal enhancement compared to adjacent parenchyma. Seminal vesicles remain uninvolved, with no evidence of extracapsular extension or suspicious lymphadenopathy." The lesion is compared against an earlier study as part of the clinical indication.
psa_trend
The PSA trend indicates: "PSA 1.9 (Jul 2023) rising to 0.7 (Jan 2024), rising to 0.9 (Aug 2024), and finally to 4.0 (Mar 2025)." This indicates a steady increase in PSA levels.
previous_notes
The management context states: "Authorization was granted for a urology referral to arrange a multiparametric MRI." The prior biopsy status is noted as "None" in the panel data. No specific surveillance protocol or planned treatment is detailed in the retrieved notes.

WHAT I DID NOT OPEN
family-history anamnesis, because it was not listed in the plan and its absence does not change the immediate decision based on the other evidence.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS = 4, which meets the EAU threshold for biopsy in a biopsy-naïve patient.
The PSA trend shows a steady increase, suggesting biological activity.
AGAINST sampling this patient now
DRE = Normal, which suggests a benign finding on physical exam.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 4.00 ng/mL over 4 points spanning 20 months; velocity +1.22 ng/mL per year; doubling time about 17 months.
PROJECTION at 6 months: 6.1 ng/mL, conformal 95% band 1.8-21.4.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 4 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.79
  uncertainty  +/- 0.07 epistemic (95% band 0.65-0.93), of which 0.01 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 4 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 56.95 mL (4% of my signal; from log_vol, vol) · PSA density = 0.07 (0% of my signal; from psad_calc) · comorbidity = none recorded (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.81  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.79  ('firm' tier, fusion_nolab; weight 4.5)
  EXPERT-EXPERIENCE  BIOPSY, p(biopsy)=0.55  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           None                         E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> noted
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          65                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          4 ng/mL                      E1:not E3:not cohort:not library:not E2:not          -> important
  vol          56.95 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.07                         E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.68                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:DEC library:DEC E2:—            -> decisive
  comorbidity  none recorded                E1:IMP E3:not cohort:not library:— E2:—              -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) have addressed the moderator's questions.

ALIGNMENT WITH THE PANEL
The retrieved evidence supports the PANEL-PROTOCOL's answer of BIOPSY, as the PI-RADS = 4 aligns with the cohort criterion (pirads_ge_3), and the PSA trend shows a steady increase.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What should be done given the PI-RADS = 4 and prior biopsy = None? The panel suggests BIOPSY based on the cohort criterion.
Q2. What does the radiology_report state regarding whether the lesion is compared against an earlier study? The report states the lesion is compared against an earlier study.
Q3. What does the psa_trend indicate regarding the steady increase in PSA levels? The trend indicates a steady increase in PSA levels.

WHAT CARRIES WEIGHT, AND WHY
pirads: decisive: 4 (from EXPERT-COHORT and EXPERT-TRACE). I agree with the PANEL-PROTOCOL's marking of this as decisive, as the EAU guideline makes the PI-RADS score the primary trigger.
prior biopsy: decisive: None (from EXPERT-STRUCTURED and EXPERT-FUSION). I agree with this being decisive, as the guideline suggests a threshold for biopsy in biopsy-naïve patients.
psa: important: 4 ng/mL (from EXPERT-STRUCTURED). I agree with this being important, as the rising PSA supports the clinical suspicion.
confidence: clear.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy based on the alignment of the PI-RADS 4 score with the EAU guideline threshold for biopsy in a biopsy-naïve patient, supported by the rising PSA trend.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

65 y/o male, biopsy-naive, PI-RADS 4 lesion warrants biopsy. The finding is driven by the PI-RADS 4 score, despite the low PSA density of 0.07. No prior pathology exists to alter this assessment. Biopsy is indicated for this new finding.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
